INTRODUCTION
monocytes/macrophages do not only represent a major target of IL-10, they are also responsible for a large part Interleukin-10 (IL-10) is a major anti-inflammatory of IL-10 production, particularly during inflammatory cytokine, originally described as a factor inhibiting IFNprocesses (3, 7, 11, 13, 17, 20) . The importance of IL-10 in γ production by murine Th1 cell (15) . Because IL-10 inflammation has been demonstrated in various experiwas preferentially produced by T cells from the Th2 mental settings. In experimental endotoxemia models, subtype and was found to be a potent inhibitor of IFN-IL-10 inhibited TNF production and rescued Balb/c γ production by Th1 cells, its action as a Th2-promoting mice from LPS-induced toxic shock (21, 26) . cytokine was proposed. More recently, IL-10 was found Viral vector-mediated gene therapies have been used to be produced by another subset of T cells called reguin clinical trials for human diseases. Previous reports latory T cells (Treg) and supposed to play a key role in have demonstrated the feasibility of using adenoviral and inhibiting autoimmune processes (36) and in promoting adeno-associated viral (AAV) vectors to deliver therathe induction of T-cell hyporesponsiveness in transplanpeutic genes (8, 9, 18, 29, 42, 51) . A special aspect of this tation (28) . All these observations point to IL-10 as a study is the use of viral IL-10 (vIL-10). The Epsteinmajor player in the regulation of the T-cell network.
Barr viral open reading frame, BCRF-1, encodes a gene Later on, the ability of IL-10 to inhibit cytokine prowith significant homology to human and murine IL-10 duction by T cells turned out to be indirect, via inhibi-(hIL-10/mIL-10) at both the nucleic acid and amino acid tion of accessory cells (16) . IL-10 acts as an inhibitor levels. The protein of BCRF-1 has been designated as of activated monocytes/macrophages functions, such as vIL-10. vIL-10 displays immunoregulatory activities cytokine synthesis, NO production, MHC class II exsimilar to hIL-10 and mIL-10 in vitro (37,50). However, pression, and costimulatory molecule expression, and vIL-10 differs from mammalian IL-10 in combining po-380 FUJISAWA ET AL. tent immunosuppressive activity on T cells/macrophages hizu Pharmaceutical Co., Ltd., Osaka, Japan), 3 nM selenium (H 2 SeO 3 , Nacalai Tesque Inc., Kyoto, Japan), 50 with rather weak immunostimulatory effects on B cells (12, 27) . vIL-10 gene expression and protein production pM zinc (ZnSO 4 7H 2 O, Ishizu Pharmaceutical Co. Ltd.), and 100 U/ml of penicillin and streptomycin (Gibco) at can be distinguished from endogenous mIL-10 in nonobese diabetic (NOD) mice by using a mAb that has no 37°C in a humidified 95% air/5% CO 2 mixture. This medium is termed hormonally defined medium (HDM) cross-reactivity to mIL-10 (51). Therefore, the kinetics of vIL-10 transgene expression can be specifically moni- (32) . At 8 h after initiating hepatocyte culture, hepatocytes were infected with adenoviral vectors (AdCMV-tored.
In this study, we demonstrate the protective effect of vIL-10, AdCMVLacZ, and DL312 ) at 1 multiplicity of infection (MOI) for 1 h at 37°C. The culture medium vIL-10 on allogeneic hepatocytes using Nagase's analbuminemic rats (NAR), which lack serum albumin due was then changed to HDM without adenoviral vectors. As described previously (19) , hepatocytes aggregate and to disorders in albumin mRNA, and show that vIL-10 induces immunoregulatory activity that can be trans-form spheroidal shapes with diameters of 80-100 µm (hepatocyte spheroids), and float in the medium for ferred by hepatocyte spheroids. The protective effect was correlated with prolonged protein production of 48-60 h after the initial infection of adenoviral vectors. vIL-10 by adenoviral vector-mediated delivery.
Transplantation of Hepatocyte Spheroids MATERIALS AND METHODS and Experimental Design Animals
The spleen of recipients was exteriorized through a left subcostal incision under ether anesthesia. The hepa-Six-to 7-week-old male WKA rats (RT1 k ) weighing 150-170 g were used as hepatocyte donors. Eight-to tocyte spheroids formed from 3 × 10 7 of isolated hepatocytes were suspended in 0.2 ml Hank's balanced salt 10-week-old male Nagase's analbuminemic rats (RT1 l ) (NAR; originally derived from out-bred Sprague-Daw-solution (HBSS) (Gibco) and injected directly into the spleen of the recipients using a 1-ml syringe with a 23-ley rats, supplied by Sasaki Institute, Tokyo) weighing 250-270 g were used as allogeneic recipients. gauge needle. Temporary clamping of the splenic vessels at the hilum was used to prevent the spheroids from Adenovirus Vectors running off into the portal vein. Animals were divided into three groups: group 1: nontransfected spheroids The adenovirus vectors, AdCMVvIL-10, AdCMVLacZ, transplantation (nontransfected STx) (n = 5), group 2: and DL312, were used for this study. AdCMVvIL-10 AdCMVvIL-10-infected spheroid transplantation (vILcontains an expression cassette encoding the CMV pro-10 STx) (n = 5), and group 3: DL312-infected spheroid moter, Epstein-Barr virus BCRF1 cDNA (vIL-10 gene), transplantation (DL312 STx) (n = 5). and a polyadenylation signal in exchange for the deleted E1a/b region. AdCMVLacZ contains an expression cas-Histopathological Assessments sette encoding the Escherichia coli LacZ gene and a polyadenylation signal. The vector DL312 is similarly Cytochemical staining for β-gal activity of the spherdeleted of E1, but does not have an insertion of foreign oids was performed at 52 h after AdCMVLacZ vector DNA. Viral titers were determined by plaque-forming infection. The spheroids were fixed in 2% formaldeassay. All vectors were adjusted to 1 × 10 8 pfu/ml and hyde/0.2% glutaraldehyde solution at 4°C for 10 min, viral stocks were stored at −80°C.
washed in phosphate-buffered saline (PBS) three times, and incubated in the solution containing 1 mg/ml of 5-Hepatocyte Isolation and Viral Infection bromo-4-chloro-3-indolyl β-galactosidase (X-gal), 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, Hepatocytes were isolated and harvested using a twostep collagenase perfusion technique (2,45). Isolated he-and 2 mM MgCl 2 in PBS. Cells expressing β-galactosidase turn blue in the presence of X-gal, while nonex-patocytes were identified by phase-contrast microscopy and more than 95% of the isolate cells were hepatocytes. pressing cells appear clear or faintly yellow. Recipients were sacrificed for histopathological studies. The re-The initial viability of the hepatocytes was above 90% as determined by trypan blue exclusion test. The isolated moved spleens were frozen and fixed in 10% buffered formalin for albumin staining, and serial sections (5 µm) hepatocytes were inoculated onto 10-cm polystyrene dishes at a density of 3 × 10 6 per dish and cultured in basal were immunostained using rabbit anti-rat albumin IgG antibodies and an immunoperoxidase avidin-biotin com-Williams' E (Sigma, St. Louis, MO, USA) supplemented with 10 mg/L bovine insulin (Gibco, NY, USA), 50 plex (Vectastain, Vector Laboratories, Burlingame, CA, USA). The removed spleens were also stained by hema-µg/L epidermal growth factor (EGF) (Sigma), 5 µg/L linoleic acid (Sigma), 0.1 µM copper (CuSO 4 5H 2 O, Is-toxylin and eosin (H&E).
Measurements of vIL-10 and Albumin Levels
Serum vIL-10 obtained from the splenic vein was detectable until day 21, with the peak of 162.7 ± 20.5 pg/ For in vitro vIL-10 and albumin production of hepaml on day 7 after the transplantation of hepatocyte tocyte spheroids, culture supernatant was collected sespheroids infected with AdCMVvIL-10. Serum vIL-10 rially. To determine serum vIL-10 and albumin levels, obtained from tail vein blood also reached a peak of recipients were sacrificed and blood samples were col-16.8 ± 4.7 pg/ml on day 7, showing correlation with the lected from the tail vein and the splenic vein at 0, 4, 7, serum vIL-10 obtained from splenic vein blood, but was 14, 21, and 28 days after hepatocyte spheroid transplanbelow the detection limit on day 21. There was a subtation. Levels of both vIL-10 and albumin were quantistantial difference in serum vIL-10 levels between tated using ELISA kits (vIL-10, Biosource International, splenic and tail vein blood (Fig. 2B) . Camarillo, CA, USA; albumin, Cayman Chemical, Massy Cedex, France).
Albumin Staining of Spleen and Serum Albumin Levels Statistical Analysis
The spleens from NARs in group 2 (vIL-10 STx Data are represented as the mean ± SEM. Student's tgroup) were sectioned and stained for albumin. Numertest was used to compare the differences among groups.
ous albumin-positive cells were observed as clusters on day 7, and there was a moderate number of albumin-RESULTS positive cells on day 14 (Fig. 3A) . In group 1 (nonβ-Galactosidase Activity (X-gal Staining)
transfected STx group), a few albumin-positive cells of Hepatocyte Spheroids were observed on day 4 (data not shown). To examine the efficacy of gene transfection, the NARs transplanted with vIL-10-transfected hepatonumber of hepatocytes stained with X-gal was counted.
cyte spheroids (group 2) showed an abrupt rise in serum The expression of X-gal was observed in 83.7 ± 2.4% of albumin levels that peaked on day 7 and persisted up to the transfected hepatocyte spheroids (Fig. 1A) . In addiday 14. The albumin levels rapidly decreased on day 21, tion, the expression of X-gal in hepatocyte spheroids getting down to baseline on day 28. In contrast, in NARs continued for at least 28 days.
transplanted with nontransfected spheroids (group 1) and DL312-transfected spheroids (group 3), the albumin Production of vIL-10 and Albumin level peaked on day 4 and returned to baseline on day by Hepatocyte Spheroids 7. The peak in group 2 was markedly higher than that In the culture medium of hepatocyte spheroids inin groups 1 and 3 ( Fig. 3B ). fected with AdCMVvIL-10 at 1 MOI for 1 h, vIL-10 production peaked on day 3 and then gradually de-DISCUSSION creased to a level about one third the peak value, but
Both T-cell activation and exploitation of the cytosteadily produced until 10 days after the commencement kine action play central roles in the initiation and proof the collection (Fig. 1B) . From day 14 onward, vILgression of rejection of allogeneic grafts (4,33). IL-10 10 was undetectable despite the sustained viability of inhibits cytokine synthesis and other functions of macrothe cultures for approximately 28 days.
phages (14, 17, 20) . IL-10 also suppresses T-cell and NK The albumin levels in the culture medium of sphercell activation/proliferation by both direct and indirect oids infected with and without AdCMVvIL-10 on day 3 effects (1,16). These activities of IL-10 render this cytowere 20.1 µg/ml and 19.5 µg/dl, respectively, and dekine a potent suppressor to the effector functions of creased from the peak on day 3. The production of almacrophages, T cells, and NK cells. In addition, IL-10 bumin per spheroid infected with AdCMVvIL-10 was most likely has stimulatory and regulatory actions on 45.1 ± 0.7 pg/spheroid/12 h, showing no significant difproliferation and differentiation of B cells, mast cells, ference from that infected without it. and thymocytes (38) .
H&E Staining of Spleen and Serum IL-10 Levels
The discovery of vIL-10 from the Epstein-Barr viral genome, BCRF-1, provides a new biological agent that In group 1 (nontransfected STx), a small number of hepatocytes was observed within the splenic paren-shares many of mammalian IL-10 activities, but differs in its reduced ability to stimulate class II MHC expres-chyma on day 2 (data not shown). On the other hand, in group 2 (vIL-10 STx), a greater number of hepatocytes sion on mouse B cells (22) and proliferation of mouse mast cells (50). vIL-10, however, lacks T-cell costimula-forming clusters within the splenic parenchyma was observed on day 7; thereafter, substantial numbers of hepa-tory activity, which authentic cellular IL-10 possesses (25) , making vIL-10 a more potent immunosuppressive tocytes were observed around the white pulp in the spleen on day 14, and hepatocytes disappeared rapidly agent for controlling allogeneic cellular rejection. By using vIL-10 as a therapeutic agent, we can monitor the on day 21 ( Fig. 2A) . In culture medium of the hepatocyte spheroids infected with AdCMVvIL-10 at 1 MOI for 1 h, vIL-10 production peaked at 1630 ± 150 pg/ml on day 3. Then its production gradually decreased, and on day 10 declined to the level about one third the peak value. kinetics of the transgene expression without confusion plantation of rat syngeneic hepatocyte spheroids can survive for longer periods with a large number than freshly of endogenous IL-10 in mammalian studies.
In this study, we used spheroidally aggregated cul-isolated hepatocytes (43, 44) . This advantage of the hepatocyte spheroids over primarily isolated hepatocytes is tured hepatocytes (spheroids) for gene transfer in allogeneic hepatocyte transplantation. It has been reported that attributed to their feasible size and shape for cell transplantation in the spleen. hepatocyte spheroids maintain cytoarchitecture similar in the native liver and well-differentiated tissue-specific A previous report demonstrated that successful gene transfer to freshly isolated hepatocytes can be achieved cellular functions such as the metabolic or synthetic capability, compared with primarily isolated hepatocytes during cold storage in UW solution using adenovirus vector (7). This procedure, however, requires long-term (32, 40, 41) . We previously reported that intrasplenic trans- Figure 2 . H&E staining of the spleen (A) and serum vIL-10 levels in the splenic and tail vein (B) in rats transplanted with hepatocyte spheroids infected with AdCMVvIL-10. The hepatocytes were detectable with morphology of spheroids being maintained on day 1. A large number of hepatocytes forming clusters were observed within the splenic parenchyma on day 7, although original morphology of spheroids was lost. On day 14, substantial numbers of hepatocytes were observed around the white pulp in the spleen on day 14 (A) (original magnification ×200; arrow, hepatocytes; arrowhead, splenocytes). Serum vIL-10 obtained from the splenic vein was detectable until day 21, with the peak on day 7 after intrasplenic transplantation of hepatocyte spheroids. Serum vIL-10 in the tail vein also reached a peak on day 7; however, it was below the limit of detection on day 21. A large difference was observed in vIL-10 levels between splenic and tail vein blood. cold preservation before transplantation, and shows in-As described above, isolated hepatocytes spontaneously aggregate after initiation of conventional mono-sufficient gene transfection compared with hepatocytes cultured in a conventional monolayered fashion. Primar-layer culture (32) . It was therefore expected that hepatocytes could be infected at the very beginning of the ily cultured hepatocytes are considered suitable for gene transfer with adenovirus vector, because they have a primary monolayer culture with an adenovirus vector, and, in fact, the efficacy of gene transfection with broad and flat surface during the culture, which facilitates efficient contact with adenovirus (19) . However, it AdCMVvIL-10 at 1 MOI for 1 h was 83.7 ± 2.4%. In addition, the present study also demonstrated that infec-is difficult to obtain free-floating isolated hepatocytes again from hepatocytes once attached and spread on tion with AdCMVvIL-10 under this condition did not affect at all albumin synthesis, a vital function of hepa-dishes. In vIL-10 STx group, serum albumin abruptly ran up to a peak (92 ± 12 mg/dl) on day 7, persisted up to day 14 (88 ± 8 mg/dl), and its level rapidly decreased down to baseline on day 28. In contrast, in nontransfected and DL312 STx groups, the serum albumin level peaked on day 4 (28 ± 2 and 16 ± 2 mg/dl, respectively) and returned to baseline on day 7 (**p < 0.01, *p < 0.05 vs. nontransfected STx group) (B). tocytes. From these results, it was evident that the for-number of hepatocyte spheroids existed on day 14 in group 2 (vIL-10 STx). Serum vIL-10 levels in splenic mation of hepatocyte spheroids is ideal for cell transplantation, as well as for gene therapy application.
vein blood in group 2 were detectable until day 21, with the peak on day 7 after the intrasplenic transplantation In this study, we investigated the effect of genetically transferred vIL-10 on the survival of transplanted alloge-of hepatocyte spheroids infected with AdCMVvIL-10. Accordingly, serum albumin levels in group 2 peaked neic hepatocyte spheroids in the spleen. Histopathological analysis revealed that most of the transplanted hepa-on day 7, remained at a high level up to 14 days, declined abruptly on day 21, and approached baseline by tocyte spheroids in group 1 (nontransfected STx) seemed to be rejected within 4 days. In contrast, a substantial day 28. On the other hand, albumin levels in group 1 showed a smaller peak on day 4 and returned to baseline the site of the transplanted cells is attractive, because systemic immunosuppression would cause several ad-within 7 days after transplantation.
These results suggested that prolonged survival of he-verse effects, as usually experienced in clinical settings. This system can be applied to human hepatocyte trans-patocyte spheroids infected with AdCMVvIL-10 in allogeneic host might be attributed to a local immuno-plantation, making it a promising modality preceding actual liver transplantation. suppressive effect induced by continuous secretion of vIL-10 from vIL-10-transfected hepatocytes in the spleen. This is further supported by detection of high REFERENCES serum levels of vIL-10 in splenic vein in recipient rats 
